Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61P - Specific therapeutic activity of chemical compounds or medicinal preparations › A61P 5 - Drugs for disorders of the endocrine system
Patents for A61P 5 - Drugs for disorders of the endocrine system (28,908)
06/2010
06/23/2010CN101745011A Method for extracting ginseng, dwarf lilyturf tuber and schisandra chinensis and preparation thereof
06/23/2010CN101745010A Extraction method of ginseng, ophiopogon root and shiandra and preparation thereof
06/23/2010CN101745009A Method for extracting ginseng, dwarf lilyturf tuber and schisandra chinensis and preparation thereof
06/23/2010CN101745008A Extraction method of ginseng, ophiopogon root and shiandra and preparation thereof
06/23/2010CN101745007A Extraction method of 'radix ophiopogonis/ginseng and schisandra chinensis' and preparation thereof
06/23/2010CN101745006A Extraction method of ophiopogon root, ginseng and shiandra and preparation thereof
06/23/2010CN101745005A Extraction method of ophiopogon root, ginseng and shiandra and preparation thereof
06/23/2010CN101745004A Method for extracting radix ophiopogonis, ginseng and schisandra chinensis as well as preparation thereof
06/23/2010CN101745003A Extraction method of ophiopogon root, ginseng and shiandra and preparation thereof
06/23/2010CN101745002A Extraction method of ophiopogon root, ginseng and shiandra and preparation thereof
06/23/2010CN101745001A Extraction method of ophiopogon root, ginseng and shiandra and preparation thereof
06/23/2010CN101745000A Extraction method of ginseng, ophiopogon root and shiandra and preparation thereof
06/23/2010CN101744999A Extraction method for ginseng, ophiopogon root and schisandra chinensis and preparation thereof
06/23/2010CN101744998A Extraction method of ginseng, ophiopogon root and shiandra and preparation thereof
06/23/2010CN101744997A Extraction method of ginseng, ophiopogon root and shiandra and preparation thereof
06/23/2010CN101744996A Extraction method of ginseng, ophiopogon root and shiandra and preparation thereof
06/23/2010CN101744995A Method for extracting ginseng, dwarf lilyturf tuber and schisandra chinensis and preparation thereof
06/23/2010CN101744994A Extraction method for ginseng, ophiopogon root and schisandra chinensis and preparation thereof
06/23/2010CN101744993A Extraction method for ginseng, ophiopogon root and schisandra chinensis and preparation thereof
06/23/2010CN101744992A Extraction method of ginseng, ophiopogon root and schisandra chinensis and preparation thereof
06/23/2010CN101744991A Single extraction method of ginseng, ophiopogon root and shiandra and preparation thereof
06/23/2010CN101744990A Method for individually extracting ginseng, radix ophiopogonis and schisandra chinensis and preparation thereof
06/23/2010CN101744989A Method for extracting schisandra chinensis, ginseng and dwarf lilyturf root and preparation thereof
06/23/2010CN101744988A Method for extracting ginseng, dwarf lilyturf tuber and schisandra chinensis and preparation thereof
06/23/2010CN101744987A Single extraction method of ginseng, ophiopogon root and shiandra and preparation thereof
06/23/2010CN101744986A Extraction method for ginseng, ophiopogon root and schisandra chinensis and preparation thereof
06/23/2010CN101744877A Selfheal quality control method
06/23/2010CN101744852A Preparation method of acanthopanax effervescent tablet and products thereof
06/23/2010CN101744842A Lipidosome Chinese traditional medicine membranous plaster
06/23/2010CN101072780B Novel tetracyclic derivative containing heteroatoms useful as sex steroid hormone receptor modulators
06/22/2010US7741343 6H-oxazolo[4,5 e]indole derivatives as nicotinic acetylcholine receptor ligands and/or serotonergic ligands
06/22/2010US7741329 such as 1-{(S)-2-[(5-Bromo-pyrimidin-2-ylamino)-methyl]-piperidin-1-yl}-1-quinolin-2-yl-methanone, used as human orexin receptor antagonist, for the treatment of obesity and insomnia
06/22/2010US7741278 Modified proteins, designer toxins, and methods of making thereof
06/22/2010CA2479991C Process for production of crystals, crystals obtained thereby and their use in pharmaceutical preparations
06/22/2010CA2469225C Citric acid salt of 4-(3,4-dichlorophenyl)-2-[2-(4-methylpiperazin-1-yl)-benzylidene]-thiomorpholin-3-one and pharmaceutical compositions thereof
06/22/2010CA2443938C Spiroindene and spiroindane compounds as opioid ligands useful for treating pain
06/22/2010CA2443633C Use of 2-alpha-cyano-4-alpha, 5-alpha-epoxyandrostan-17-beta-ol-3-one derivatives for lowering levels of serum cortisol and for the treatment of clinical conditions associated thereof
06/22/2010CA2406177C 8.beta.-hydrocarbyl-substituted estratrienes as selectively active estrogens
06/22/2010CA2389553C Heteroaryl-diazabicycloalkanes
06/17/2010WO2010068500A2 PROGESTATIONAL 3-(6,6-ETHYLENE-17b-HYDROXY-3-OXO-17a-PREGNA-4-ENE-17a -YL) PROPIONIC ACID g-LACTONES
06/17/2010WO2010066852A1 Composition comprising isoflavones
06/17/2010WO2010043566A3 Combination of an insulin and a glp-1 agonist
06/17/2010US20100152149 Formulation
06/17/2010US20100152148 Novel compounds
06/17/2010US20100152118 Agonists of guanylate cyclase useful for the treatment of hypercholesterolemia, atherosclerosis, coronary heart disease, gallstone, obesity and other cardiovascular diseases
06/17/2010US20100150993 Transdermal therapeutic system comprising norelestromin for contraception and hormone replacement
06/17/2010US20100150984 Bio-artificial pancreas and a procedure for preparation of same
06/17/2010US20100150893 Methods of organ regeneration
06/17/2010CA2746251A1 Composition comprising isoflavones
06/16/2010EP2195315A1 Substituted bicyclic piperidinyl-and piperazinyl- sulfonamides useful to inhibit 11 -hydroxysteroid dehydrogenase type-1
06/16/2010EP2195030A1 Isoflavone formulation
06/16/2010EP2194969A1 Acid containing lipid formulations
06/16/2010EP1809271B1 Use of (r)-(halobenzyloxy) benzylamino-propanamides as sodium and/or calcium channel selective modulators
06/16/2010EP1645566B1 Analogs of parathyroid hormone
06/16/2010EP1625847B1 Medical use of a tetrahydrotriazolo[4,3-a]pyrazine
06/16/2010EP1436281B1 Piperidine- and piperazineacetamides as 17beta hydroxysteroid dehydrogenase type 3 inhibitors for the treatment of androgen dependent diseases
06/16/2010CN1960739B Functional food for ameliorating engogenous melatonin secretion rhythm and functional food for ameliorating circadian rhythm
06/16/2010CN1731981B Liposome of glucocorticoids
06/16/2010CN101743316A Enzymatic process for obtaining 17 alpha-monoesters of cortexolone and/or its 9,11-dehydroderivatives
06/16/2010CN101735267A Water-soluble (R)-(-)-bicalutamide pre-medicament, preparation method and application thereof
06/15/2010US7737136 high affinity agonists; high specificity; side effect reduction; endometriosis; hormone dependent cancers, fertility control; dibenzo[b,f]pyrido[1,2-d][1,4] oxazepin, dibenzo[b,f]pyrido[1,2-d][1,4]thiazepim, dibenzo[b,f]pyrido[1,2-d][1,4]diazepin and dibenzo[c,f]pyrido[1,2-a]azepine derivatives
06/15/2010US7735485 Dry powder inhalation system for transpulmonary administration
06/15/2010CA2299495C Process for preparing growth hormone secretagogues
06/10/2010WO2010065567A2 Methods and compositions for altering health, wellbeing, and lifespan
06/10/2010US20100144687 Pharmaceutical compositions containing testosterone and an aromatase inhibitor
06/10/2010US20100144684 Method of Safely and Effectively Treating and Preventing Secondary Hyperparathyroidism in Chronic Kidney Disease
06/10/2010US20100144665 Treatment of statin side effects
06/10/2010US20100144632 Administering a polypeptide having at least one of anti-angiogenic, tumor-suppressive, or anti-migratory activity, but does not have stimulation of cell proliferation activity
06/10/2010US20100144605 Rescue of gonadotropin releasing hormone receptor mutants
06/10/2010US20100143314 In Vivo Production and Delivery of Erythropoietin or Insulinotropin for Gene Therapy
06/10/2010US20100143287 Trifluoromethylphenyl modulators of calcium-sensing receptor
06/10/2010CA2745376A1 Methods and compositions for altering health, wellbeing, and lifespan
06/09/2010EP2194045A1 Substituted pyrazole derivative
06/09/2010EP1497273B1 Hydroxamic acid derivatives
06/09/2010CN1771239B Vitamin d3 lactone derivatives
06/09/2010CN1662511B Pharmaceutical salts of reboxetine
06/09/2010CN1646115B Use of SARMS in preparing medicine for treating benign prostate hyperplasia
06/09/2010CN101724075A Remodeling and glycoconjugation of peptides
06/09/2010CN101723947A Dipeptidase-IV inhibitor compound
06/09/2010CN101721687A Insulin-hydroxyapatite nano compound, preparation method and application thereof
06/09/2010CN101721653A Traditional Chinese medicine for treating hyperthyroidism
06/09/2010CN101721376A Calcitonin sustained release microsphere composition and preparation method thereof
06/09/2010CN101721375A Insulin slow release micron sphere composition and preparation method thereof
06/08/2010US7732603 Organic compounds as agents for the treatment of aldosterone mediated conditions
06/08/2010US7732487 Administering calcium channel modulators such as 13,14-dihydro 15-keto-16,16-difluoroprostaglandin E1, for prophylaxis of brain, cardiovascular, gastrointerstinal, respiratory system, vision or liver disorders
06/08/2010US7732456 such as 4-benzyloxy-1-{4-[2-(dimethylamino)ethoxy]phenyl}-1H-pyridin-2-one, that as antagonists to melanin concentrating hormone receptors, used for treating cardiovascular, nervous system, metabolic, reproductive system, respiratory system and gatrointestinal disorders
06/08/2010US7732442 N-[5-bromo-3-({3-[2-(dimethylamino)ethoxy]-4-methoxybenzyl}oxy)pyridin-2-yl]-4-methylbenzenesulfonamide, used for prevention and/or treatment of infections, inflammatory and/or allergic diseases
06/08/2010US7732422 TRPM-2 antisense therapy
06/08/2010US7732412 Methods of treatment using novel LHRH antagonists having improved solubility properties
06/08/2010US7732146 Method for screening an agent that modulates activity of macrophage migration inhibitory factor
06/08/2010CA2467222C Use of estrogenic compounds in combination with progestogenic compounds in hormone-replacement therapy
06/08/2010CA2447178C Pharmaceutical composition for use in hormone replacement therapy
06/08/2010CA2439241C Bipiperidinyl-derivatives and their use as chemokine receptors inhibitors
06/08/2010CA2431983C Novel 1,2-diphenylazetidinones, processes for their preparation, medicaments comprising these compounds and their use for treating impaired lipid metabolism
06/03/2010WO2010061971A1 Pyridine-3-carboxyamide derivative
06/03/2010WO2010061030A1 Isolation of multipotent hypophysary cells and in vitro differentiation thereof
06/03/2010WO2010060836A1 Arylcyclohexylethers of dihydrotetraazabenzoazulenes for use as vasopressin via receptor antagonists
06/03/2010WO2010027498A3 Compositions and methods for inducing satiety and treating non-insulin dependent diabetes emillitus, pre-diabetic symptoms, insulin resistance and related disease states and conditions
06/03/2010US20100137430 Treating androgen decline in aging male (adam)-associated conditions with sarms
06/03/2010US20100137389 Topical formulation
1 ... 47 48 49 50 51 52 53 54 55 56 57 58 59 60 61 62 63 64 65 66 67 ... 290